This session provides an overview of the principles of safety reporting associated with marketed medicinal products including spontaneous reporting systems.

Have an account?

Drug Safety and Pharmacovigilance Across the Product Lifecycle

Session 11: Post-Marketing Safety Principles and Spontaneous Case Reporting

Session Chair(s)

Mark Vieder, MBA, RPh

Be informed and stay engaged.